Home ›
NPI 1336675560
NPI deactivated
1336675560
1336675560 was paid $1.47M by Medicaid between Jan 2018 and Mar 2022, across 80 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider info1336675560
33aNPI1336675560
33bProvider type—
28Total paid$1.47M
24GClaims60,111
24DCodes billed80
24AFirst – last monthJan 2018 – Mar 2022
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,682 | $97K | |
| 2019 | 14,060 | $370K | |
| 2020 | 12,240 | $385K | |
| 2021 | 17,107 | $548K | |
| 2022 | 2,022 | $73K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 8,007 | 7,340 | $372K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 5,888 | 5,342 | $350K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 11% | 3,201 | 3,153 | $158K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 9.6% | 1,618 | 1,586 | $141K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.4% | 607 | 602 | $50K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.1% | 3,742 | 3,597 | $46K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.4% | 3,113 | 3,035 | $35K |
| X5622 | 1.7% | 1,603 | 1,378 | $25K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.6% | 321 | 320 | $23K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.4% | 688 | 679 | $21K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.3% | 277 | 262 | $19K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 7,054 | 6,585 | $18K |
68 more codes
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.1% | 1,226 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 1,129 | $16K |
| 80061 | Lipid panel | <1% | 1,085 | $14K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 165 | $13K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 757 | $12K |
| 92551 | <1% | 1,518 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,203 | $9K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 338 | $9K |
| 87081 | <1% | 1,410 | $9K | |
| 85027 | <1% | 1,578 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 853 | $7K |
| 96127 | <1% | 1,995 | $7K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 667 | $7K |
| 83970 | <1% | 132 | $6K | |
| 84439 | <1% | 630 | $6K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 272 | $5K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 58 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 95 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 95 | $4K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 544 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 474 | $3K |
| 90686 | <1% | 799 | $3K | |
| 84481 | <1% | 146 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 419 | $3K |
| 99188 | <1% | 669 | $3K | |
| 81001 | <1% | 1,141 | $3K | |
| 80050 | General health panel | <1% | 44 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 315 | $2K |
| 90682 | <1% | 43 | $2K | |
| 99173 | <1% | 1,586 | $2K | |
| 84207 | <1% | 57 | $2K | |
| 82607 | <1% | 107 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 16 | $1K |
| 83735 | <1% | 197 | $1K | |
| 0071A | <1% | 29 | $1K | |
| 81025 | <1% | 247 | $1K | |
| 0072A | <1% | 32 | $944.43 | |
| 82746 | <1% | 49 | $841.64 | |
| 86803 | <1% | 52 | $816.21 | |
| 87210 | <1% | 141 | $797.38 | |
| 0001A | <1% | 16 | $777.19 | |
| 84100 | <1% | 159 | $740.58 | |
| 0002A | <1% | 15 | $733.20 | |
| 90651 | <1% | 101 | $600.23 | |
| 81003 | <1% | 226 | $499.59 | |
| 80076 | <1% | 57 | $387.71 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 13 | $291.06 |
| 90670 | <1% | 192 | $222.81 | |
| 87807 | <1% | 15 | $222.10 | |
| 80047 | <1% | 99 | $189.20 | |
| 86780 | <1% | 15 | $188.24 | |
| 85652 | <1% | 53 | $161.93 | |
| 86140 | <1% | 25 | $147.05 | |
| 96161 | <1% | 97 | $120.02 | |
| 85018 | <1% | 24 | $60.04 | |
| 90715 | <1% | 24 | $56.92 | |
| 92552 | <1% | 43 | $19.51 | |
| 90734 | <1% | 77 | $0.34 | |
| 90723 | <1% | 58 | $0.34 | |
| 90647 | <1% | 82 | $0.28 | |
| 90633 | <1% | 29 | $0.14 | |
| 90687 | 0% | 100 | $0.00 | |
| 82947 | 0% | 20 | $0.00 | |
| 90685 | 0% | 44 | $0.00 | |
| 82248 | 0% | 12 | $0.00 | |
| 36416 | 0% | 56 | $0.00 | |
| 90698 | 0% | 13 | $0.00 | |
| 82728 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.